Fact CheckerSign in

NCT07080827Active, not recruiting

TTM-Based Social Media Psychoeducation for Psychosis

The Effect of Transtheoretical Model-Based Psychoeducation Via Social Media on Treatment Adherence in Individuals Diagnosed With Psychosis

Source: ClinicalTrials.gov · Last updated 23 Jul 2025

Brief summary (registry, in English)

This doctoral research investigates the effect of a Transtheoretical Model (TTM)-based psychoeducation program delivered via social media on treatment adherence in individuals diagnosed with psychosis. The study follows a randomized controlled trial design with pretest, posttest, and three-month follow-up assessments. A total of 60 participants were selected from among 354 individuals registered at the Balıkesir Community Mental Health Center (CMHC), based on predefined inclusion and exclusion criteria. Participants were randomly assigned into three groups: 1. an online intervention group receiving a 5-week TTM-based treatment adherence psychoeducation program via WhatsApp; 2. a face-to-face intervention group receiving a standard, non-TTM-based treatment adherence psychoeducation program over 3 weeks at the CMHC; and 3. a control group that received no educational intervention, only assessments. Data collection instruments include a Sociodemographic Information Form, the Stage of Change Identification Form, the Medication Adherence Report Scale (MARS-5), and the Clinical Global Impression-Severity Scale (CGI-S). Measurements were conducted at baseline, post-intervention, and three months after the intervention. The study hypotheses are: Research Hypotheses H1: The treatment adherence scale scores of individuals diagnosed with psychosis who participate in the TTM-based psychoeducation group administered via social media will differ compared to the scores of individuals who participate in the face-to-face treatment adherence psychoeducation group. H2: The treatment adherence scale scores of individuals diagnosed with psychosis who participate in the TTM-based psychoeducation group administered via social media will differ compared to the scores of individuals who do not receive TTM-based psychoeducation. This study aims to provide evidence for the efficacy of theory-based, technology-supported psychoeducation programs in enhancing treatment adherence among individuals with psychosis. Furthermore, it evaluates whether a model-based online psychoeducation program is more effective than a conventional treatment adherence education.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
11 Jul 2025
Start date
Mar 2025
Primary completion date
Apr 2025
Lead sponsor
Istanbul University - Cerrahpasa
NCT number
NCT07080827

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From Mar 2025 to the primary completion date, Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Comorbid psychiatric diagnoses not covered under the inclusion list
  • Diagnosed with neurocognitive disorders (e.g., dementia)

Age

  • Under 18 or over 65 years of age

Other

  • Acute psychotic episode at the time of recruitment
  • Diagnosed with intellectual disability (mental retardation)
  • Unable to use smartphone, tablet, or other digital communication tools
  • Missed more than 20% of the intervention sessions

Who the study is looking for

  • Age between 18 and 65 years
  • Diagnosed with a psychotic disorder according to DSM-5 criteria, including:
  • Schizophrenia
  • Schizophreniform disorder
  • Schizoaffective disorder (with mild mood symptoms)
  • Brief psychotic disorder
  • Substance/medication-induced psychotic disorder (in remission)
  • Paranoid disorder
  • On the same prescribed psychiatric medication for at least one month
  • Able to communicate in Turkish
  • Has access to the internet and owns at least one active social media account (Instagram, Twitter, Facebook, WhatsApp, etc.)
  • Literate and able to complete self-report forms
  • Willing to participate and provide informed consent
  • Clinical Global Impression-Severity (CGI-S) score of 4 or below

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Balıkesir Provincial Health Directorate, Community Mental Health Center
Coordinator of this site? Confirm its status
BalıkesirTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.